The Aptamers Market is gaining significant momentum as biopharmaceutical companies and research institutions increasingly adopt aptamer-based technologies for drug discovery, diagnostics, and targeted therapy. Characterized by high specificity, low immunogenicity, and superior binding affinity compared to antibodies, aptamers are emerging as a vital tool in modern molecular medicine....
English